[HTML][HTML] Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
RS Finn, S Qin, M Ikeda, PR Galle… - … England Journal of …, 2020 - Mass Medical Soc
Background The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
RS Finn, S Qin, M Ikeda, PR Galle… - The New England …, 2020 - europepmc.org
Background The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
[引用][C] Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
RS Finn, D Li, W Verret, S Hernandez, Y Wang… - New England Journal …, 2020 - elibrary.ru
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
IMbrave150 Investigators - New England …, 2020 - mdanderson.elsevierpure.com
BACKGROUND The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
R Finn, S Qin, M Ikeda, P Galle, M Ducreux, T Kim… - 2020 - covid19.neicon.ru
BACKGROUND The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
RS Finn, S Qin, M Ikeda, PR Galle… - The New England …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
[PDF][PDF] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
RS Finn, S Qin, M Ikeda, PR Galle, M Ducreux… - N Engl J …, 2020 - cdn.doctorsonly.co.il
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma Page 1 The
new england journal of medicine n engl j med 382;20 nejm.org May 14, 2020 1894 The …
new england journal of medicine n engl j med 382;20 nejm.org May 14, 2020 1894 The …
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
IMbrave150 Investigators - New England Journal of …, 2020 - snucm.elsevierpure.com
BACKGROUND The combination of atezolizumab and bevacizumab showed encouraging
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
antitumor activity and safety in a phase 1b trial involving patients with unresectable …
[PDF][PDF] Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
MK Kim, V Breder, P Merle, AO Kaseb, D Li, W Verret… - eemh.gr
Περίληψη Εισαγωγή: Ο συνδυασμός atezolizumab και bevacizumab φάνηκε να έχει
ενθαρρυντικά αποτελέσματα ως προς την καταστολή καρκινικής δραστηριότητας καθώς και …
ενθαρρυντικά αποτελέσματα ως προς την καταστολή καρκινικής δραστηριότητας καθώς και …
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
RS Finn, S Qin, M Ikeda, PR Galle, M Ducreux… - New England Journal …, 2020 - cir.nii.ac.jp
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …